SAMDaily.us | AWARD | A | Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains

SAMDAILY.US - ISSUE OF OCTOBER 16, 2025 SAM #8725
AWARD

A -- Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains

Notice Date: 10/14/2025 3:58:45 AM
Notice Type: Award Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Solicitation Number: 75A50125C00008
Archive Date: 10/29/2025
Point of Contact: BARDA-BAA@hhs.gov, Ryan Marion
E-Mail Address: BARDA-BAA@hhs.gov, ryan.marion@hhs.gov
(BARDA-BAA@hhs.gov, ryan.marion@hhs.gov)
Small Business Set-Aside: NONE No Set aside used
Award Number: 75A50125C00008
Award Date: 07/25/2025
Awardee: OSIVAX Paris 8 �le-de-France 75008 FRA
Award Amount: 98593151.00
Web Link: SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/1fce5ad56c2d466390a77292391a9d9d/view)
Place of Performance: Address: Paris 8 75008, FRA; Zip Code: 75008; Country: FRA
Record: SN07617406-F 20251016/251014230031 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |